Am. J. Respir. Crit. Care Med., Volume 165, Number 2, January 2002, 236-241

Increased Macrophage Inflammatory Protein-1 and Macrophage Inflammatory Protein-1 Levels in Bronchoalveolar Lavage Fluid of Patients Affected by Different Stages of Pulmonary Sarcoidosis

ARMANDO CAPELLI, ANTONINO DI STEFANO, MIRCO LUSUARDI, ISABELLA GNEMMI, and CLAUDIO F. DONNER

"Salvatore Maugeri" Foundation, Istituto de Ricovero e Cura a Carattere Scientifico (IRCCS), Scientific Institute of Veruno (Italy), Division of Pulmonary Disease, Veruno, Italy

Macrophage inflammatory protein (MIP)-1 and MIP-1 are two CC chemokines that induce lymphocyte migration. MIP-1 preferentially mediates chemotaxis of CD8 rather than CD4 lymphocytes, whereas the reverse is true for MIP-1. Both these chemokines recognize CCR5 as a cellular receptor in T lymphocytes and alveolar macrophages. We measured the concentrations of MIP-1 and MIP-1 in bronchoalveolar lavage fluid (BALF) of 30 subjects affected by different stages of pulmonary sarcoidosis and 18 healthy normal subjects. We also evaluated the expression of CCR5 in alveolar macrophages and lymphocytes. The BALF concentrations of MIP-1 were significantly increased only in Stage II and III sarcoidosis. On the contrary, the concentrations of MIP-1 were significantly increased at all stages. A striking increase of CCR5 expression was observed in both lymphocytes and macrophages of all patients, along with a trend to decreased positivity from Stage I to III of the disease. The MIP-1 concentrations correlated with the number of total (r = 0.65, p = 0.0001) and both CD4 (r = 0.64, p = 0.0001) and CD8 (r = 0.62, p = 0.0001) lymphocytes; on the contrary, the MIP-1 concentrations correlated only with CD8 lymphocytes (r = 0.45, p = 0.002). Finally, significant negative correlations were observed between the neutrophil percentage and CCR5 expression in alveolar macrophages (r = 0.53, p = 0.005) and lymphocytes (r = 0.43, p = 0.01). Our results help to explain the mechanism of CD4 and CD8 recruitment and the possible involvement of CC chemokines in the fibrotic progression of sarcoidosis.

This article has been cited by other articles:

				I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas Roles of T lymphocytes in pulmonary fibrosis J. Leukoc. Biol., February 1, 2008; 83(2): 237 - 244. [Abstract] [Full Text] [PDF]

				E. Kriegova, C. Melle, V. Kolek, B. Hutyrova, F. Mrazek, A. Bleul, R. M. du Bois, F. von Eggeling, and M. Petrek Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1145 - 1154. [Abstract] [Full Text] [PDF]

				M. Takeuchi, K. Oh-i, J. Suzuki, T. Hattori, A. Takeuchi, Y. Okunuki, Y. Usui, and M. Usui Elevated Serum Levels of CXCL9/Monokine Induced by Interferon-{gamma} and CXCL10/Interferon-{gamma}-Inducible Protein-10 in Ocular Sarcoidosis. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1063 - 1068. [Abstract] [Full Text] [PDF]

				P. Spagnolo, E. A. Renzoni, A. U. Wells, S. J. Copley, S. R. Desai, H. Sato, J. C. Grutters, A. Abdallah, A. Taegtmeyer, R. M. du Bois, et al. C-C Chemokine Receptor 5 Gene Variants in Relation to Lung Disease in Sarcoidosis Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 721 - 728. [Abstract] [Full Text] [PDF]

				A. Capelli, A. Di Stefano, I. Gnemmi, and C. F. Donner CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Eur. Respir. J., April 1, 2005; 25(4): 701 - 707. [Abstract] [Full Text] [PDF]

				K. W. Thomas and G. W. Hunninghake Sarcoidosis JAMA, June 25, 2003; 289(24): 3300 - 3303. [Full Text] [PDF]

				A. Gibejova, F. Mrazek, D. Subrtova, V. Sekerova, J. Szotkowska, V. Kolek, R. M. du Bois, and M. Petrek Expression of Macrophage Inflammatory Protein-3{beta}/CCL19 in Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1695 - 1703. [Abstract] [Full Text] [PDF]

				H. Fehrenbach, G. Zissel, T. Goldmann, T. Tschernig, E. Vollmer, R. Pabst, and J. Muller-Quernheim Alveolar macrophages are the main source for tumour necrosis factor-{alpha} in patients with sarcoidosis Eur. Respir. J., March 1, 2003; 21(3): 421 - 428. [Abstract] [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]